Skip to content

Comparison of Treatments in Venous Insufficiency

The Utility of Novel Ambulatory Treatment Techniques in Venous Insufficiency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01298908
Enrollment
231
Registered
2011-02-18
Start date
2007-10-31
Completion date
2015-12-31
Last updated
2016-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Insufficiency

Keywords

varicose veins, oedema

Brief summary

Randomized controlled trial, a method used to implement the random allocation sequence is numbered containers. The aim of the study is to compare operative treatment, ultrasound guided laser ablation and ultrasound guided foam sclerotherapy in occluding/ablating of insufficiency in great saphenous trunks. On the grounds of the available data, the study hypothesis is that using laser or operative treatment more than 20 percent better outcome can be achieved compared to foam sclerotherapy.

Detailed description

In operative treatment the great saphenous vein will be removed after flush ligation by femoral vein and stripping of the trunk. In intravenous laser treatment a thin laser fiber is inserted through a tiny distal entry point. The probe is guided into place using ultrasound and the procedure is performed under local tumescence anesthesia. Laser energy is delivered to seal the faulty vein. Ultrasound guided foam sclerotherapy involves an injection of foam (sodium tetradecyl sulfate mixed with air according to the Thessari method) directly into the venous trunk under ultrasound control. In each group patients will use supportive treatment stockings 2 weeks after treatment. The patients in all groups are followed up one year by ultrasound scanning.

Interventions

In operative treatment the great saphenous vein will be removed after flush ligation by femoral vein and stripping of the trunk.

In intravenous laser treatment a thin laser fiber is inserted through a tiny distal entry point. The probe is guided into place using ultrasound and the procedure is performed under local tumescence anesthesia. Laser energy is delivered to seal the faulty vein.

Ultrasound guided foam sclerotherapy involves an injection of foam (sodium tetradecyl sulfate mixed with air according to the Thessari method) directly into the venous trunk under ultrasound control.

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* patients with chronic superficial vein insufficiency * patient must be 20-70 years old * degree of difficulty of vein insufficiency C2-C4 * average diameter of refluxing great saphenous vein 4 -10 mm * patient is agreeable to the study

Exclusion criteria

* peripheral atherosclerotic occlusive disease * lymphoedema * severe concomitant disease * venous ulcers or unclassified skin changes * BMI more than 40 * pregnancy * allergy to the foam used in sclerotherapy or to local anaesthetics * coagulation disorder * bilateral vein insufficiency (equal symptoms)

Design outcomes

Primary

MeasureTime frameDescription
Recanalization or reflux of the treated venous trunkat 1 and 12 monthsResults will be verified by Duplex scanning

Secondary

MeasureTime frameDescription
Symptom reliefat 1 and 12 monthsSymptoms will be evaluated by using CEAP-classification and degree of disability
Complications related to procedureat 1 and 12 monthsAt 1 month follow-up immediate complications will be recorded. At 12 months follow-up appearance of late complications and pain and incapacity for work due to the procedure will be recorded.
Quality of lifeat 1 and 12 monthsQuality of life is evaluated with two questionnaires: Aberdeen (which is a 13-item questionnaire with categories related specially to disadvantages caused by varicose veins) and 15D (a questionnaire with categories related to general quality of life)

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026